Cabot Wealth Network
Chris Preston is an investment analyst and web content editor for the Cabot Wealth Network website. He is also a news writer for Cabot's free Wall Street's Best Daily e-newsletter, and contributes to other Cabot advisories and special projects. He was previously an analyst and assistant managing editor with Wyatt Investment Research. Mr. Preston has been a professional writer for over 10 years, picking up two writing awards along the way.
Chris Preston and Brad Simmerman of Cabot Wealth Network discuss what era in market history this volatile period most closely resembles.
Chris Preston and Brad Simmerman of Cabot Wealth Network sit down with Larry Cheung, CFA, a Chinese investing expert. Fresh off a two-week trip to China, Larry reveals which two Chinese sectors he views as "green shoot" opportunities, and how to play them.
Eli Lilly (LLY) and Novo Nordisk (NVO) have been two of the market's biggest success stories this year thanks to booming demand for their new diabetes/weight loss drugs, Mounjaro, Ozempic, and Wegovy, states Chris Preston of Cabot Wealth Network.
Cabot Options Institute Chief Analyst Andy Crowder explained how he wins 80% of his trades during earnings season, states Chris Preston of Cabot Wealth Network.